NAD

NAD Recommends Unilever Discontinue Certain Claims for ‘Degree MotionSense’, ’Clinical Protection’ Products Following P&G Challenge

The NAD has recommended that Unilever United States, Inc. discontinue certain comparative performance claims for the company’s Degree MotionSense and Degree Clinical Protection antiperspirants. The claims at issue were made in broadcast advertising and challenged by The Procter & Gamble Company, the maker of Old Spice and Secret antiperspirants.

Read More

NAD Finds P&G Can Support ‘Toughest Messes’ Claim for Cascade Platinum, but Recommends Company Discontinue Side-by-Side Demonstration

The NAD has determined that The Procter & Gamble Company can support the claim that Cascade Platinum dishwasher liquid “powers through your toughest messes.” NAD recommended, however, that P&G discontinue a side-by-side product demonstration.

Read More

NAD Recommends DraftKings Discontinue ‘Largest U.S.-Based’ Claims Following FanDuel Challenge

NAD recommended that DraftKings, Inc., discontinue claims that the company’s website, DraftKings.com, is the “largest U.S.-based” fantasy sports or online gaming destination. The claims at issue were challenged by FanDuel.com, owner of a competing fantasy sports website.

Read More

NAD Recommends Prestige Discontinue Certain Claims for ‘Little Remedies’ Products, Finds Product Name is Not Misleading

NAD has recommended that Prestige Brands Holdings, Inc., discontinue certain advertising claims for two of the company’s “Little Remedies” products formulated with honey. However, NAD determined that the advertiser could support a challenged claim made for Little Remedies Honey Cough Syrup and found that the products’ name – Little Remedies – was not misleading.

Read More

Natural Factors Discontinues Certain Claims for ‘Theracurmin’ in Response to NAD Inquiry; NAD Recommends Additional Modifications

The NAD has recommended that Natural Factors, Inc., modify or discontinue certain claims for the company’s Theracurmin line of curcumin dietary supplements. Following its review of the company’s advertising, NAD determined that the company could support certain claims.

Read More

Xenex Discontinues Claims for ‘Germ-Zapping Robots’ Following NAD Inquiry; Claims at Issue – Including Ebola Disinfectant Claims – Challenged by Clorox

Xenex Disinfection Services LLC has said it has either discontinued or will discontinue certain advertising claims for the company’s “Germ-Zapping Robots.” The claims were challenged before the National Advertising Division by The Clorox Company.

Read More